# Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

> **NCT03554265** · PHASE3 · COMPLETED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 72 (actual)

## Conditions studied

- Traumatic Brain Injury
- Fatigue
- Cognitive Impairment
- COVID-19

## Interventions

- **DRUG:** Somatropin

## Key facts

- **NCT ID:** NCT03554265
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-06
- **Primary completion:** 2023-10-04
- **Final completion:** 2023-10-04
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03554265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03554265, "Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03554265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*